» Articles » PMID: 29864420

Natural History of Colonic Polyposis in Young Patients with Familial Adenomatous Polyposis

Overview
Date 2018 Jun 5
PMID 29864420
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Proctocolectomy prevents colorectal cancer in familial adenomatous polyposis (FAP). Colorectal polyp progression is one of the indications for surgery. No data exist regarding the natural history of colorectal polyposis in young patients with FAP. This study examined the rate of polyposis progression and factors associated with it.

Methods: Patients with FAP <30 years old who had undergone ≥2 colonoscopies since 2000 were identified. Rate of polyposis progression was calculated by review of polyp counts obtained from baseline and last colonoscopy, accounting for any polyps removed during the observation period. Endoscopic and non-endoscopic factors affecting the rate of polyposis progression were evaluated. Multivariate analysis was performed to identify factors associated with rate of polyposis progression.

Results: One hundred sixty-eight patients (52% female; median age, 13.5 years) were included. Median rate of polyposis progression was 25.4 polyps/year (interquartile range, 9.5-69.8). Highest median rate of polyposis progression (89 polyps/year) was associated with mutation in codon 1309. The rate of polyposis progression was independently associated with the location of mutation in the adenomatous polyposis coli gene, the number of polyps at the initial colonoscopy, and exposure to chemoprevention. Of the 39.9% of patients who underwent surgery, an increase in polyp number was the most common indication (53.7%).

Conclusions: The rate of polyposis progression in young patients with FAP varies with a median of about 25 new polyps per year. Progression is associated with distinct factors, which can be used in discussion with patients regarding the need for and timing of prophylactic colorectal surgery.

Citing Articles

Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint....

Zaffaroni G, Mannucci A, Koskenvuo L, de Lacy B, Maffioli A, Bisseling T Br J Surg. 2024; 111(5).

PMID: 38722804 PMC: 11081080. DOI: 10.1093/bjs/znae070.


Surgical Decision-Making in Familial Adenomatous Polyposis.

Steinberger A, Westfal M, Wise P Clin Colon Rectal Surg. 2024; 37(3):191-197.

PMID: 38617844 PMC: 11007598. DOI: 10.1055/s-0043-1770732.


Diffuse benign inflammatory gastric polyps: A rare case in a young female: Case report and review of the literature.

Zhang Z, Guo Z, Zhang J, Yu X Front Surg. 2023; 9:1090622.

PMID: 36684282 PMC: 9851379. DOI: 10.3389/fsurg.2022.1090622.


Microbiome insights into pediatric familial adenomatous polyposis.

Attard T, Septer S, Lawson C, Attard M, Lee S, Umar S Orphanet J Rare Dis. 2022; 17(1):416.

PMID: 36376984 PMC: 9664625. DOI: 10.1186/s13023-022-02569-2.


Using genotype to assist clinical surveillance: a retrospective study of Chinese familial adenomatous polyposis patients.

Ge S, Cheng D, Zhang X, Xu T, Wang Z, Dong F Am J Cancer Res. 2022; 12(9):4254-4266.

PMID: 36225625 PMC: 9547999.